Sentences with phrase «identification of cancer»

Often, early identification of cancer is the difference between life and death.

She is particularly interested in the identification of cancer driver mutations, genes and pathways across tumor types and in the study of their targeted opportunities.

Such targeting and ease of identification of cancer cells could allow oncologists to spot even tiny numbers of diseased cells in a biopsy sample.

The study results challenge the current paradigm of microarray data analysis and suggest that the new method may improve identification of cancer - associated genes.

The identification of the cancer cell of origin has important clinical implications, as it enables doctors to detect malignancies earlier and predict tumor behavior more accurately.

Not exact matches

Proteocyte Diagnostics, a company with a unique test for early identification of oral cancers, announced today that it has officially joined MaRS» SVX (Social Venture Connexion).

Proteocyte Diagnostics Inc., a company with a unique test for early identification of oral cancers, today announced an investment by Freycinet Investments, made possible by MaRS» SVX (Social Venture Connexion) impact investing platform.

TORONTO, July 15, 2014 — Proteocyte Diagnostics, a company with a unique test for early identification of oral cancers, announced today that it has officially joined MaRS» SVX (Social Venture Connexion).

«NTP has not written a report which «concludes» that 4 - MEI «causes cancer,» nor has NTP otherwise identified 4 - MEI as «causing cancer» in the way that phrase is used by NTP and regulatory agencies with respect to the identification of chemicals as posing a carcinogenic hazard.»

Dr. Peter Infante, a former director of the Office of Carcinogen Identification and Classification at the Occupational Safety and Health Administration, called the NAS critique «arrogant» because «we don't know the mode of action for most things that cause cancer.»

They are working together to mesh her identification of compounds that target tumors with runaway Ras activity and tumor data (analyzed by machine learning) to find patients who could benefit from these potential cancer drugs.

The discovery that the identification and biopsy of the first lymph node to which a cancer spreads (the sentinel node) can lead to more accurate diagnosis and treatment has revolutionised the management of breast cancer.

A new tracer can enable surgeons to make an accurate identification of the sentinel node — the lymph node to which cancer spreads first — and hence spare patients the post-operative complications that may be linked to the removal of a group of lymph nodes in the neck.

When the results were compared with studies in the literature using standard radiocolloid tracers the researchers found that the SN biopsy using tilmanocept provided a high identification rate and low false negative rate for SNs, thus facilitating accurate prediction of the spread of the cancer.

Much like the association between BRCA gene mutation and the risk for breast cancer in women changed the approach to treatment / prevention, the identification of the Kallikrein 6 gene region may change the course of prostate cancer care through a blood test developed by the Lunenfeld - Tanenbaum Research Institute.

Identification of a specific genetic mutation in patients with non-small-cell lung cancer (NSCLC) helps clinicians select the best treatment option.

«Despite the identification of circulating tumor cells (CTCs) and cell - free DNA (cfDNA) as biomarkers capable of providing clinically relevant information in cancer patients, at present their identification is not routinely used in clinical practice,» explains Silvia Morbelli, MD, PhD, of the IRCCS San Martino — IST National Cancer Research Institute and University of Genoa in Genoa, cancer patients, at present their identification is not routinely used in clinical practice,» explains Silvia Morbelli, MD, PhD, of the IRCCS San Martino — IST National Cancer Research Institute and University of Genoa in Genoa, Cancer Research Institute and University of Genoa in Genoa, Italy.

In the Journal of Biophotonics and the Analyst they compared conventional procedures for colon cancer identification with a novel method called label - free spectral histopathology.

«The identification and initial validation of a highly accurate 5 - gene pancreatic cancer biomarker panel that can discriminate late and early stages of pancreatic cancer from normal pancreas and benign pancreatic lesions could facilitate early diagnosis of pancreatic cancer,» said co-senior author Roya Khosravi - Far, PhD, Associate Professor of Pathology at BIDMC.

The identification of dormant niches in basement membrane microvasculature and how those niches become metastatic in the neovasculature holds important implications for future breast cancer therapies.

This analysis led to the identification of several lncRNAs that are overexpressed in a particular subset of ovarian cancer, those that are thought to be the most aggressive.

His research interests include the molecular underpinnings of cervical cancer (including developing genetic screens), the identification of the genetic determinants of quantitative traits in humans, and the application of massively parallel sequencing technology for understanding the genetics of complex disease.

The discovery of EBV paved the way for the identification of other cancer - causing viruses, including human papillomavirus (HPV), and hepatitis B.

The enrichment factor described how frequently cancer associated genes were identified compared to the frequency of identification that one could expect by pure chance.

- Identification of anti-hypertension drugs as potential therapeutics against breast and pancreatic cancer metastasis was a big surprise.

«The identification of HPV - negative endometrial - like tumors confirms that not all cervical cancers are related to HPV infection and that a small percentage of cervical tumors may be due to strictly genetic or other factors,» noted Jean - Claude Zenklusen, Ph.D., director of NCI's TCGA program office.

«Identification of these variations has helped the family to better understand why their children developed cancer and to plan for the future,» said co-author Kim Nichols, M.D., a member of the St. Jude Oncology department and director of the St. Jude Cancer Predisposition Divcancer and to plan for the future,» said co-author Kim Nichols, M.D., a member of the St. Jude Oncology department and director of the St. Jude Cancer Predisposition DivCancer Predisposition Division.

Much like mutation of the gene BRCA marks people at risk to develop breast and ovarian cancers, identification of mutations in the gene ETV6 may allow doctors to predict the development of ALL, allowing increased monitoring and in the future, perhaps strategies to prevent the disease.

Research fields are diverse, including basic research on cell proliferation, analysis of tumour cells and tissues to detect gene mutations, and identification of potential therapeutic targets in cancer.

These guidelines affirm early identification, treatment, and ongoing assessment for psychological distress as important aspects of prostate cancer survivorship care.

The identification of patients with high - risk breast cancer is key to knowing whether a patient will require only the removal of the tumor by surgery or whether if she will need additional chemotherapy to make sure the removal of breast cancer cells.

Identification and functional validation of proteins involved in tumorigenesis are essential steps toward advancing cancer precision medicine.

The identification of novel molecular targets for cancer can be a challenge.

Dr. Cole's research interests include cancer genomics and the identification of molecularly targeted therapies for pediatric malignancies.

Technology such as this, scientists said, may have a promising future in the identification and surgical removal of malignant tumors, as well as using near - infrared light therapies that can kill remaining cancer cells, both by mild heating of them and generating reactive oxygen species that can also kill them.

The identification of genes that are synthetically lethal in β - catenin - activated cancer cells would provide new targets for therapeutic drug design.

Identification of oxidized protein hydrolase as a potential prodrug target in prostate cancer.

Identification of those men at greatest risk for prostate cancer development and progression would provide a means of targeted screening, thereby reducing unnecessary testing, false positive tests, and the burden of overdiagnosis and over treatment.

The team's identification of a direct cooperation between these two cancer genes paves the way for targeted treatments - not only in ALL, but also in other leukemias where JAK3 / STAT5 could cooperate with HOXA9.

Identification of proangiogenic TIE2 - expressing monocytes (TEMs) in human peripheral blood and cancer.

Further research uncovered a broad spectrum of cell surface stem cell markers (e.g., CD133, CD44, and CD24) that allow the identification of CSCs in human solid tumors, including brain, breast, prostate, pancreas, liver, ovary, skin, colon cancers, and melanoma (3 - 6)(Figure 1 based on 7).

In 1989, Vogelstein's identification of p53 gene mutations in colon cancer began a tide of research linking alterations in the gene to other cancers.

Identification of a human papillomavirus - associated oncogenic miRNA panel in human oropharyngeal squamous cell carcinoma validated by bioinformatics analysis of the Cancer Genome Atlas.

Joan is recognized «for his important contributions to understand the development of cancer, in particular, why cancers evolve with mutations that are poorly immunogenic, and also for the identification of special hepatic reparative cells with low propensity to produce cancer».

IRB Barcelona has named Joan Font - Burgada (Caldes de Montbui, Barcelona, 1977) winner of the 2018 IRB Barcelona Alumni of Excellence Award «for his important contributions to understand the development of cancer, in particular, why cancers evolve with mutations that are poorly immunogenic, and also for the identification of special hepatic reparative cells with low propensity to produce cancer,» states the report by the jury — a body formed by senior IRB Barcelona researchers with expertise across several fields of research.

$ 1.8 M Supports Cancer Drug Discovery on Commonly Mutated Gene New Brunswick Patch — April 5, 2016 Behavioral Scientist Shares Insights about FDA's Proposed Rule on Banning Tanning Bed Use among Minors News-Medical.net - March 19, 2016 Intervention Program Reduces Caregiver Distress during Hospitalization of Pediatric Stem Cell Transplant Patients News-Medical.net - March 9, 2016 Exploring Genomic Pathways in the Development of Ovarian Cancer GMNews.com - March 2, 2016 Differences in Type of Small Protein may further Elucidate Lung Cancer Risk in African Americans ScienceDaily.com - March 2, 2016 Study Looks at Post-Treatment Resources for Prostate Cancer Patients Transitioning to Survivorship News-Medical.net - February 11, 2016 Drawing the Line on Tanning Bed Use by Teens ScienceDaily.com - December 21, 2015 What Rutgers Study Uncovered about E-Cigarette Use NJBiz.com - December 9, 2015 Identification of Barrier that Prevents Progression of Benign Kidney Tumors to Malignant Disease MedicalNewsToday.com - November, 24, 2015 What is the Color of the Lung Cancer Ribbon?

The characterization of the genetic alterations observed in neuroblastoma led to the identification of major players of neuroblastoma oncogenesis that has considerably improved our understanding of the biology of this pediatric cancer.

Understanding these pathways, and the identification of the key proteins that control the ability of cancer cells to reprogram their metabolism through biochemical, and epigenetic or genetic alterations that make them resistant to therapies, is of paramount importance for the design of more targeted and therefore less toxic therapies.

Identification of six new susceptibility loci for invasive epithelial ovarian cancer.

The Conquer Cancer Foundation is a public charity exempt from federal income tax under Section 501 (c)(3) of the Internal Revenue Code and the organization's Federal Identification Number (EIN) is 31-1667995.